Definitive Contract HHSO100201600010C

Award Date 4/21/16
Potential Completion Date 4/20/17
Potential Value $404K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
St. Petersburg, FL 33716, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $84,382.00 firm fixed price purchase order awarded by the Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of Roche Magna Pure Kits/Zika and does not have a set-aside designation. Roche Diagnostics has been awarded numerous federal contracts and...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the maintenance of COBAS HIV with Operations capabilities. The award, which has a ceiling value of $572,044.24 and an ultimate completion date of September 4, 2028, does not have a set-aside designation. Roche Diagnostics, a foreign-owned for-profit manufacturer of in vitro diagnostic products, has received...
This contract award to Roche Diagnostics Corporation (Roche) is for the COBAS AMPLIPREP TAQMAN HIV-1 TEST V 2.0. The contract, which has a ceiling value of $109,459.97, was awarded by the U.S. Army Medical Command (MEDCOM) for the delivery of this diagnostic test and is a firm fixed price Blanket Purchase Agreement (BPA) call. The contract does not have a set-aside designation. Roche is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...
This is a Firm Fixed Price contract awarded by the Department of the Air Force (AFLCMC Wright Patterson AFB) to Roche Diagnostics Corporation for COVID-19 ROCHE MICRO AUTOMATED MOLECULAR TESTING PLATFORM AT USAFSAM EPIDEMIOLOGY LABORATORY - KITS AND REAGENTS. The contract was awarded on February 25, 2021 with a completion date of March 2, 2021 and a ceiling value of $89,159. The contract was placed as a BPA Call under Roche's existing GSA Schedule 66-III contract for Critical Analyzers and...
This is a Firm Fixed Price contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of COVID-19 ROCHE MICRO AUTOMATED MOLECULAR TESTING PLATFORM equipment, kits, and reagents to the U.S. Air Force School of Aerospace Medicine (USAFSAM) Epidemiology Laboratory. The contract, valued at $40,510.00, was awarded on April 18, 2020 through a Blanket Purchase Agreement (BPA) call against Roche's General Services Administration (GSA) Schedule contract...
This is a firm fixed price BPA Call contract awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense (DoD) to Roche Diagnostics Corporation for the COBAS AMPLIPREP TAQMAN HIV-1 TEST V 2.0. The $107,455.61 contract provides clinical diagnostic equipment and consumables to support healthcare services for veterans, active duty military personnel, dependents, retirees, and civilian patients. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents,...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The award is a delivery order under Roche's General Services Administration (GSA) Federal Supply Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). The award provides Roche's COBAS AMPLIPREP/COBAS TAQMAN HIV-1 Test Version 2, a viral load...
This is a $223,250.16 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, for preventive maintenance of a Cobas 6800 blood chemistry analyzer at a VA facility in Puerto Rico. The contract has a base year and four one-year options, and was awarded without a set-aside designation. Roche Diagnostics has previously received awards from the VA, Department of Defense, and other federal agencies...
This is a federal contract award from the Defense Health Agency (DHA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for COBAS ASSAY laboratory testing services. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price ceiling value of $66,994.48 and a period of performance through September 30, 2024. This award does not have a set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents,...
The U.S. Department of Health and Human Services (HHS) awarded a $2,665,898 firm-fixed-price contract to Diasorin Inc., a foreign-owned, for-profit company, for the provision of automated immunoassays to detect Zika virus IgM and IgG antibodies. This contract is not associated with any set-aside designations. As part of this effort, Diasorin has subcontracted with Boca Biolistics, LLC, a for-profit company, to provide characterized human blood specimens for use in the development of the Zika...

This is a definitive, firm-fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Roche Molecular Systems, Inc. for COBAS ZIKA TESTING FOR PUERTO RICO BLOOD SUPPLY. The contract has a ceiling value of $404,498.68 and a completion date of April 20, 2017. There was no set-aside used for this award. The contract is for the provision of COBAS ZIKA testing services to ensure the safety of the Puerto Rico blood supply.

Generated 4/1/25, 8:09 PM